Polymyxin B Sulfate;Oxytetracycline Hcl
174 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
174
Total Reports
6
Deaths Reported
340.0%
Death Rate
Active Ingredients
Polymyxin B Sulfate;Oxytetracycline Hcl
Administration Routes
UnknownOphthalmicIntraocularTopicalOral
Species Affected
Unknown 83
Cat 71
Dog 17
Human 2
Goat 1
Most Affected Breeds
Unknown 85
Domestic Shorthair 39
Cat (other) 18
Domestic Mediumhair 4
Ragdoll 3
Chihuahua 3
Dog (unknown) 3
Retriever - Labrador 3
Bulldog 2
Siamese 2
Most Reported Reactions
Color, Abnormal 39
Underfilling, Container 17
Vomiting 16
Containers, Leaking 14
Containers, Damaged 12
Swelling around eye 10
Lack of efficacy - NOS 9
Lethargy (see also Central nervous system depression in 'Neurological') 8
Corneal ulcer 8
Swollen eye 7
Ocular discharge 7
Conjunctivitis 6
Outcome Breakdown
Ongoing
37 (40.2%)
Outcome Unknown
29 (31.5%)
Recovered/Normal
19 (20.7%)
Died
3 (3.3%)
Euthanized
3 (3.3%)
Recovered with Sequela
1 (1.1%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.